Prevention & Lipids
Cholesterol treatment and ASCVD risk reduction
Also called cholesterol, dyslipidemia, lipid lowering
Sources: updated Oct 1, 2026
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Synthesized from 1 evidence-backed clinical questions on Lipid management — 1 no benefit shown.
The placed evidence leans toward no benefit
0
Favor benefit
0% of all
1
No benefit shown
100% of all
Low certainty on 100% of questions
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.